Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung

被引:7
作者
Ueda, Takuya [1 ,2 ,3 ,4 ,5 ]
Aokage, Keiju [2 ]
Nishikawa, Hiroyoshi [6 ]
Neri, Shinya [7 ]
Nakamura, Hiroshi [1 ,3 ,4 ,5 ]
Sugano, Masato [3 ,4 ]
Tane, Kenta [2 ]
Miyoshi, Tomohiro [2 ]
Kojima, Motohiro [1 ]
Fujii, Satoshi [1 ]
Kuwata, Takeshi [3 ,4 ]
Ochiai, Atsushi [8 ]
Kusumoto, Masahiko [9 ]
Suzuki, Kenji [5 ]
Tsuboi, Masahiro [2 ]
Ishii, Genichiro [1 ]
机构
[1] Natl Canc Ctr, Div Pathol, Exploratory Oncol Res & Clin Trial Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East, Dept Thorac Surg, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Dept Pathol, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr Hosp East, Clin Labs, Kashiwa, Chiba, Japan
[5] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan
[6] Natl Canc Ctr, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[7] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan
[8] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[9] Natl Canc Ctr Hosp East, Dept Diagnost Radiol, Chiba, Japan
关键词
Lung squamous cell carcinoma; Usual interstitial pneumonia; PD-L1; Tumor immunity; Tumor microenvironment; IDIOPATHIC PULMONARY-FIBROSIS; REGULATORY T-CELLS; PD-L1; EXPRESSION; PROGNOSTIC VALUE; CANCER; SURVIVAL; GROWTH; MOUSE;
D O I
10.1007/s00432-018-2602-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Patients with usual interstitial pneumonia (UIP) often develop lung cancer. However, the biological features of lung cancer associated with UIP remain unknown. The aim of this study was to elucidate the clinicopathological characteristics of UIP-associated squamous cell carcinoma (SqCC). Methods A total of 244 patients with p-stage I lung SqCC who underwent complete surgical resection were enrolled in this study. Clinicopathological differences between UIP-associated SqCC and non-UIP SqCC were examined. Moreover, we performed immunohistochemical studies to clarify the biological differences between these two groups. Results UIP-associated SqCC was detected in 19 patients (6.0%). Patients with UIP-associated SqCC tended to have shorter recurrence-free survival (RFS) (5-year RFS; UIP-associated SqCC 44% vs non-UIP SqCC 62%, p = 0.05). Immunohistochemical analysis revealed that the expression scores of cancer stem cell- and invasion-related molecules in cancer cells were not significantly different between the two groups. However, PD-L1 expression in cancer cells was significantly higher in UIP-associated SqCC (median score; 5.0 vs 0, p < 0.01). In the stroma of UIP-associated SqCC, the number of Foxp3(+) tumor-infiltrating lymphocytes was significantly higher than that in non-UIP SqCC (median number 43/HPF vs 24/HPF, p < 0.01). In addition, CD8(+)/Foxp3(+) T-cell ratio in UIP-associated SqCC was significantly lower than that in non-UIP SqCC (median ratio 1.8 vs 3.4, p < 0.01). Conclusion Our current study clearly revealed that the establishment of an immunosuppressive tumor microenvironment is a characteristic feature of UIP-associated SqCC, which can be correlated with poor prognosis in UIP-associated SqCC.
引用
收藏
页码:835 / 844
页数:10
相关论文
共 31 条
[1]  
American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277
[2]  
Archontogeorgis K, 2012, LUNG CANCER, V2012, DOI [10.1155/2012/315918, DOI 10.1155/2012/315918]
[3]   Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall- cell lung cancer [J].
Azuma, K. ;
Ota, K. ;
Kawahara, A. ;
Hattori, S. ;
Iwama, E. ;
Harada, T. ;
Matsumoto, K. ;
Takayama, K. ;
Takamori, S. ;
Kage, M. ;
Hoshino, T. ;
Nakanishi, Y. ;
Okamoto, I. .
ANNALS OF ONCOLOGY, 2014, 25 (10) :1935-1940
[4]  
Cardone A, 1997, PANMINERVA MED, V39, P174
[5]   Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells [J].
Chen, Xin ;
Subleski, Jeffrey J. ;
Kopf, Heather ;
Howard, O. M. Zack ;
Maennel, Daniela N. ;
Oppenheim, Joost J. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (10) :6467-6471
[6]   The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J].
Goldstraw, Peter ;
Crowley, John ;
Chansky, Kari ;
Giroux, Dorothy J. ;
Groome, Patti A. ;
Rami-Porta, Ramon ;
Postmus, Pieter E. ;
Rusch, Valerie ;
Sobin, Leslie .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :706-714
[7]   Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC) [J].
Guo, Qinxiang ;
Sun, Yu ;
Yu, Sifan ;
Bai, Hua ;
Zhao, Jun ;
Zhuo, Minglei ;
Wang, Jie .
THORACIC CANCER, 2017, 8 (02) :73-79
[8]   Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment [J].
Ishii, Genichiro ;
Ochiai, Atsushi ;
Neri, Shinya .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 99 :186-196
[9]   Lung cancer in patients with idiopathic pulmonary fibrosis [J].
Karampitsakos, Theodoros ;
Tzilas, Vasilios ;
Tringidou, Rodoula ;
Steiropoulos, Paschalis ;
Aidinis, Vasilis ;
Papiris, Spyros A. ;
Bouros, Demosthenes ;
Tzouvelekis, Argyris .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 :1-10
[10]   The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK [J].
Le Jeune, Ivan ;
Gribbin, Jonathan ;
West, Joe ;
Smith, Chris ;
Cullinan, Paul ;
Hubbard, Richard .
RESPIRATORY MEDICINE, 2007, 101 (12) :2534-2540